Chief Executive Officer
Gösta Hiller joined SDS in early 2017 and holds a PhD in Cell and Molecular Biology from Lund University, Sweden. Prior to joining SDS, Gösta worked as a preclinical researcher, screening and characterizing new chemical series and as a clinical and global project manager for several years and he brings more than 15 years´ drug development experience to SDS. His role is to assist clients at both strategic and operational levels, particularly in the delivery of early and late stage clinical development programs involving both small molecules and biologics. Gösta is also SDS’s Chief Executive Officer.
phone +46 723 725 958